{"transactions":[{"id":3610447,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Leveraged Restricted Stock Unit","published_at":"2019-03-05T21:12:52.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":85594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each leveraged stock unit (\"LSU\") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These LSUs vest on March 2, 2022"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These LSUs do not expire"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each leveraged stock unit (\"LSU\") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A common stock."}],"balance_after":85594,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":85594},"source":{"system":"sec-edgar","filing":"0001628908-19-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890819000008/primary_doc.xml","form_type":"4"}},{"id":3815116,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (Right to buy)","published_at":"2018-09-14T20:47:01.000Z","date":"2018-09-13","kind":"exercise","acquired":false,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised vested on December 1, 2014 and December 1, 2015."}],"balance_after":108274,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001628908-18-000070","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000070/primary_doc.xml","form_type":"4"}},{"id":3815115,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-09-14T20:47:01.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":70000,"price":27.5,"value":1925000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $27.50-$27.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":67868,"source":{"system":"sec-edgar","filing":"0001628908-18-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000070/primary_doc.xml","form_type":"4"}},{"id":3815114,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-09-14T20:47:01.000Z","date":"2018-09-13","kind":"exercise","acquired":true,"shares":70000,"price":3.84,"value":268800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":137868,"source":{"system":"sec-edgar","filing":"0001628908-18-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000070/primary_doc.xml","form_type":"4"}},{"id":3826935,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-09-04T20:50:09.000Z","date":"2018-08-30","kind":"sale","acquired":false,"shares":30000,"price":25,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $25.00-$25.025, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":67868,"source":{"system":"sec-edgar","filing":"0001628908-18-000067","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000067/primary_doc.xml","form_type":"4"}},{"id":3852708,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2018-08-03T21:15:33.000Z","date":"2018-08-01","kind":"sale","acquired":false,"shares":10000,"price":19.96,"value":199600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $19.60-$20.40, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":97868,"source":{"system":"sec-edgar","filing":"0001628908-18-000060","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000060/primary_doc.xml","form_type":"4"}},{"id":3872233,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-07-05T20:38:35.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":10000,"price":21.21,"value":212100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is as weighted average. These shares were sold in multiple transactions at prices ranging from $20.60-$21.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":107868,"source":{"system":"sec-edgar","filing":"0001628908-18-000055","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000055/primary_doc.xml","form_type":"4"}},{"id":3904371,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-06-05T22:01:13.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":10000,"price":20.04,"value":200400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $19.65-$20.40, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":117868,"source":{"system":"sec-edgar","filing":"0001628908-18-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000037/primary_doc.xml","form_type":"4"}},{"id":3930187,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-05-16T20:31:37.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":10000,"price":18.91,"value":189100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $18.65-$19.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":127868,"source":{"system":"sec-edgar","filing":"0001628908-18-000033","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000033/primary_doc.xml","form_type":"4"}},{"id":4075595,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2018-02-05T22:32:20.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":58923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Securities vest at a rate of 25% annually beginning February 1, 2019."}],"balance_after":58923,"derivative":{"exercise_price":13.95,"expiration_date":"2028-02-01","underlying":"Class A Common Stock","underlying_shares":58923},"source":{"system":"sec-edgar","filing":"0001628908-18-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000007/primary_doc.xml","form_type":"4"}},{"id":4075594,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-05T22:32:20.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":25090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Peterson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 25% annually beginning February 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":137868,"source":{"system":"sec-edgar","filing":"0001628908-18-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890818000007/primary_doc.xml","form_type":"4"}},{"id":4250685,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-07-26T20:43:50.000Z","date":"2017-07-24","kind":"exercise","acquired":false,"shares":14033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options vested on December 1, 2014."}],"balance_after":178274,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":14033},"source":{"system":"sec-edgar","filing":"0001628908-17-000037","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890817000037/primary_doc.xml","form_type":"4"}},{"id":4250684,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-07-26T20:43:50.000Z","date":"2017-07-24","kind":"sale","acquired":false,"shares":26507,"price":26,"value":689182.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $26.00-$26.025, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":112778,"source":{"system":"sec-edgar","filing":"0001628908-17-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890817000037/primary_doc.xml","form_type":"4"}},{"id":4250683,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-07-26T20:43:50.000Z","date":"2017-07-24","kind":"sale","acquired":false,"shares":14033,"price":26,"value":364858.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $26.00-$26.025, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":139285,"source":{"system":"sec-edgar","filing":"0001628908-17-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890817000037/primary_doc.xml","form_type":"4"}},{"id":4250682,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-07-26T20:43:50.000Z","date":"2017-07-24","kind":"exercise","acquired":true,"shares":14033,"price":3.84,"value":53886.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":153318,"source":{"system":"sec-edgar","filing":"0001628908-17-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890817000037/primary_doc.xml","form_type":"4"}},{"id":4307661,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-23T22:27:33.000Z","date":"2017-05-19","kind":"sale","acquired":false,"shares":57433,"price":24.3,"value":1395621.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":139285,"source":{"system":"sec-edgar","filing":"0000950157-17-000722","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000095015717000722/form4.xml","form_type":"4"}},{"id":4315074,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-17T22:42:35.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":20777,"price":24.99,"value":519217.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.85-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":278761,"source":{"system":"sec-edgar","filing":"0001643498-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000003/primary_doc.xml","form_type":"4"}},{"id":4315073,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-17T22:42:35.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":20777,"price":24.99,"value":519217.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.85-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":299538,"source":{"system":"sec-edgar","filing":"0001643498-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000003/primary_doc.xml","form_type":"4"}},{"id":4315072,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-17T22:42:35.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":20777,"price":24.99,"value":519217.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.90-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":320315,"source":{"system":"sec-edgar","filing":"0001643498-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000003/primary_doc.xml","form_type":"4"}},{"id":4315071,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-17T22:42:35.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":20777,"price":25,"value":519425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.90-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":341092,"source":{"system":"sec-edgar","filing":"0001643498-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000003/primary_doc.xml","form_type":"4"}},{"id":4317703,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-05-16T22:09:01.000Z","date":"2017-05-12","kind":"exercise","acquired":true,"shares":9328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class A Common Stock Options exercised began vesting at a rate of 25% annually beginning December 1, 2014."}],"balance_after":192307,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":9328},"source":{"system":"sec-edgar","filing":"0001643498-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000002/primary_doc.xml","form_type":"4"}},{"id":4317702,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-16T22:09:01.000Z","date":"2017-05-12","kind":"sale","acquired":false,"shares":17114,"price":25,"value":427850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $25.00-$25.05, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":361869,"source":{"system":"sec-edgar","filing":"0001643498-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000002/primary_doc.xml","form_type":"4"}},{"id":4317701,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-16T22:09:01.000Z","date":"2017-05-12","kind":"sale","acquired":false,"shares":9328,"price":25,"value":233200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."}],"balance_after":378983,"source":{"system":"sec-edgar","filing":"0001643498-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000002/primary_doc.xml","form_type":"4"}},{"id":4317700,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-16T22:09:01.000Z","date":"2017-05-12","kind":"exercise","acquired":true,"shares":9328,"price":3.84,"value":35819.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."}],"balance_after":388311,"source":{"system":"sec-edgar","filing":"0001643498-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000002/primary_doc.xml","form_type":"4"}},{"id":4322229,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-05-12T23:18:46.000Z","date":"2017-05-10","kind":"exercise","acquired":false,"shares":6265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised began vesting at a rate of 25% annually beginning December 15, 2014."}],"balance_after":201635,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":6265},"source":{"system":"sec-edgar","filing":"0001643498-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000001/primary_doc.xml","form_type":"4"}},{"id":4322228,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-12T23:18:46.000Z","date":"2017-05-10","kind":"sale","acquired":false,"shares":12339,"price":25,"value":308475.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $25.00-$25.025, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":378983,"source":{"system":"sec-edgar","filing":"0001643498-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000001/primary_doc.xml","form_type":"4"}},{"id":4322227,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-12T23:18:46.000Z","date":"2017-05-10","kind":"sale","acquired":false,"shares":6265,"price":25,"value":156625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares sold in multiple transactions at prices ranging from $25.00-$25.025, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":391322,"source":{"system":"sec-edgar","filing":"0001643498-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000001/primary_doc.xml","form_type":"4"}},{"id":4322226,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-12T23:18:46.000Z","date":"2017-05-10","kind":"exercise","acquired":true,"shares":6265,"price":3.84,"value":24057.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016."}],"balance_after":395587,"source":{"system":"sec-edgar","filing":"0001643498-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164349817000001/primary_doc.xml","form_type":"4"}},{"id":4467786,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-02-04T00:33:36.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":30637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Securities vest at a rate of 25% annually beginning February 1, 2018."}],"balance_after":30637,"derivative":{"exercise_price":18.25,"expiration_date":"2027-02-01","underlying":"Class A Common Stock","underlying_shares":30637},"source":{"system":"sec-edgar","filing":"0000950157-17-000196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000095015717000196/form4.xml","form_type":"4"}},{"id":4467785,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-04T00:33:36.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":13699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Peterson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 25% annually beginning February 1, 2018."}],"balance_after":391322,"source":{"system":"sec-edgar","filing":"0000950157-17-000196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000095015717000196/form4.xml","form_type":"4"}},{"id":4602371,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159437,"kind":"person","name":"Peterson Thomas III","position":1,"cik":"0001643498","reported_name":"Peterson Thomas III","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2016-09-15T20:50:40.000Z","date":"2016-09-14","kind":"sale","acquired":false,"shares":72827,"price":21.54,"value":1568693.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $21.54 represents the public offering price of $22.50 per share of Class A Common Stock less the underwriters' discount of $0.96 per share."}],"balance_after":377623,"source":{"system":"sec-edgar","filing":"0000950157-16-002177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000095015716002177/form4.xml","form_type":"4"}}]}